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1  | INTRODUC TION
Posterior reversible encephalopathy syndrome (PRES) is a clinico- 
radiological syndrome (Lee, Wijdicks, Manno, & Rabinstein, 2008). 
Clinical symptoms are headache, visual disturbance, mental al-
teration, and seizure. The characteristic radiologic finding is the 
vasogenic edema in the posterior part of the brain (Bartynski, 
2008a,b). Diverse brain imaging patterns are currently reported with 
the advances of the imaging techniques (McKinney, Jagadeesan, & 
Truwit, 2013). The elimination or correction of the predisposing 
factors usually ensures the favorable outcomes. The mechanism 
behind the brain edema development is controversial. The failure 
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Abstract
Objective: The effect of blood pressure (BP) on the lesion distribution of posterior 
reversible encephalopathy syndrome (PRES) is controversial. The aim of this study 
was to identify the relationship between brain lesion distribution patterns and BP.
Methods: Sixty- five patients with PRES were selected from the database. Data re-
garding brain MRI findings, clinical symptoms, medical conditions, and BP at the pr-
esymptomatic period (24 hr before the symptom onset) and at the symptom onset 
were collected. The brain lesion distribution degree was numerically calculated (le-
sion scoring point [LSP]) and compared with BP and medical conditions.
Results:	Mean	onset-	MAP	was	higher	than	mean	pre-	MAP.	Pre-	MAP	correlated	with	
onset-	MAP.	The	LSP	was	significantly	correlated	with	pre-	MAP	(p = 0.009, correla-
tion coefficient [cc] = 0.323), whereas no significant correlation was found between 
LSP	and	onset-	MAP	(p = 0.159, cc = 0.177). Similarly, when patients were grouped by 
mean	MAP	values,	LSP	was	significantly	higher	in	the	patients	with	high	MAP	at	the	
presymptomatic period (p = 0.004), whereas no difference was found in the LSP 
value	 between	 patients	 with	 low	 MAP	 and	 high	 MAP	 at	 the	 symptom	 onset	
(p = 0.272).
Conclusion: The patient with PRES who has relatively higher BP in the presympto-
matic period would be more likely to have wider lesion distribution than the patient 
with lower BP. BP elevation during presymptomatic period may be a heralding sign of 
impending PRES and a factor affecting the severity of PRES although BP was not in-
vestigated at earlier time points.
K E Y W O R D S
blood pressure, lesion scoring point, magnetic resonance imaging, posterior reversible 
encephalopathy syndrome
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of auto- regulation caused by severe hypertension or direct toxic 
insult to endothelium is the most popular theory for pathophys-
iology (Bartynski, 2008b; Dinsdale, 1983; Schwartz et al., 1995; 
Strandgaard, Olesen, Skinhoj, & Lassen, 1973). One of the unsettled 
questions about PRES is the correlation between the brain lesion 
distribution patterns and blood pressure (BP). The aim of this study 
is to identify the relationship between brain lesion distribution pat-
terns and BP.
2  | METHODS
2.1 | Data collection
We investigated patients with PRES who were admitted to Severance 
Hospital	between	 January	2001	and	December	2014.	All	 patients	
had been admitted already at least 24 hr before the symptom onset. 
Diagnosis of PRES was based on clinical features (predisposing 
conditions, headache, seizures, mental alteration, and visual dis-
turbances); multifocal lesions on MRI, mainly suggesting vasogenic 
edema; clinical recovery; and when available, reversibility of MRI 
lesions. Clinical information such as past medical histories, comor-
bid illnesses, brain magnetic resonance imaging (MRI), BP measured 
1 day before the symptom onset (pre- BP), and BP checked (onset-
 BP) at symptom onset (mental alteration, seizure, severe headache, 
or visual disturbances) was collected. BP had been measured every 
at least 8 hr. BP measured between 24 and 32 hr before the symp-
tom onset was regarded as BP 1 day before the symptom onset. 
Mean	 arterial	 pressure	 (MAP)	 was	 calculated	 using	 the	 formula:	
Mean arterial pressure = 2/3 diastolic BP + 1/3 systolic BP.
Cases with unclear symptom onset, without BP documentation, 
without brain MRI, with pre- existing neurologic deficits, or with a 
history	of	seizure	disorder	were	excluded.	As	a	 result,	65	patients	
were selected. This study was approved by the Institutional Review 
Board of Severance Hospital.
2.2 | Brain imaging and brain lesion distribution
Brain MRI using either 1.5- T (Signa Horizon, GE Medical System, 
Milwaukee, WI, or Gyroscan Intera, Philips Medical Systems, 
Best,	 The	Netherlands)	 or	 3.0-	T	 scanner	 (Achieva,	 Philips	Medical	
Systems, Best, The Netherlands), including conventional spin- echo 
T1- weighted axial, T2- weighted axial, and fluid- attenuated inversion 
recovery axial sequences, were commonly reviewed in all the pa-
tients. The mean time to the MRI evaluation was 1.6 days (range, 
0–6 days).
The lesion distribution of the PRES was determined by one ex-
perienced	 neuro-	radiologist	 (SK	 Lee).	Affected	 brain	 regions	were	
tabulated as frontal, parietal, occipital, temporal lobes, basal ganglia 
(BG), thalamus, brain stem (BS), and cerebellum (Cbll). Each brain re-
gion was scored as one point, and then the scores from the brain 
regions were added up (lesion scoring point, LSP) in each patient 
(Figure 1).
2.3 | Statistical analysis
Statistical analysis was performed using SPSS (version 20) for 
Windows	 (IBM	Corp.,	 Armonk,	NY,	 USA).	 The	 Chi-	square,	Mann–
Whitney U, Spearman’s correlation, and Kruskal–Wallis tests were 
used to determine the statistical significance (p < 0.05).
F IGURE  1 The lesion scoring method. Two sample cases are illustrated. O, occipital lobe; T, temporal lobe; BS, brain stem; F, frontal lobe; 
P, parietal lobe; Cbll, cerebellum; N, no; Y, yes; LSP, lesion scoring point
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3  | RESULTS
3.1 | Patients profiles, clinical symptoms, and 
prognosis
All	 patients	 were	 in-	hospital	 onset	 PRES	 cases.	 Forty-	eight	 pa-
tients (73.8%) of 65 were female. The mean age was 40.0 years 
(median, 36 years; range, 11–90). Underlying medical conditions 
were as follows: chemotherapy- immunosuppression (n = 26), renal 
failure (n = 22), preeclampsia- eclampsia (n = 10), autoimmune dis-
ease (n = 9), isolated uncontrolled hypertension (n = 4), and others 
(n = 6; transfusion [n = 2], acute intermittent porphyria [n = 2], burn 
[n = 1], and pancreatitis [n = 1]) (Table 1). Multiple medical condi-
tions were found in 12 patients of 65. Visual disturbances including 
blurred vision, hemianopsia, hallucination, and cortical blindness 
were present in 31 patients (47.7%), headache was present in 42 
(64.6%), seizure was present in 51 (78.5%), limb weakness was pre-
sent in 7 (10.8%), and mental alteration was found in 36 (55.4%) of 
65 patients.
3.2 | Brain lesion distribution
Cerebral cortical or subcortical lesions were found in 63 (96.9%) of 
the 65 patients. Two (3.1%) of the 65 patients did not have cere-
bral cortical or subcortical lesions. These individuals had lesions in 
deep nuclei or BS. The cerebral lesion locations were occipital in 56 
(86.2%), parietal in 54 (83.1%), frontal in 44 (67.7%), and temporal 
in 38 (58.5%) of the 65 patients. BG, thalamus, BS, and Cbll lesions 
were identified in 13 (20.0%), 12 (18.5%), 8 (12.3%), and 17 (26.2%) 
of 65 patients. There was no significant relationship between the 
medical condition and the specific brain region preference except 
for the BG involvement in patients with preeclampsia- eclampsia. 
Five of 10 patients with preeclampsia- eclampsia had lesions in BG 
(p = 0.010).
3.3 | Relationship among lesion distribution, 
BP, and etiology
The mean time of BP measurement before the symptom 
onset	 was	 27.2	±	2.5	hr	 (range,	 24–31	hr).	 The	 mean	 MAP	 was	
99.7 ± 13.8 mmHg (range, 73.3–133.3 mmHg) at the presympto-
matic period and 133.0 ± 21.2 mmHg (range, 81.3–183.3 mmHg) at 
the	 symptom	onset	 in	 the	 total	 patients.	The	onset-	MAP	was	 sig-
nificantly	higher	than	pre-	MAP	(p < 0.001). In the brain lesion scor-
ing, the mean LSP was 7.1 ± 3.1 (range, 1–14) in the total patients 
(Figure 2).
In the correlation analysis of BP and scoring point, LSP correlated 
with	pre-	MAP	 (p = 0.009, correlation coefficient [cc] = 0.323). Pre- 
MAP	correlated	with	onset-	MAP	(p < 0.001, cc = 0.424). No signifi-
cant	correlation	was	found	between	LSP	and	onset-	MAP	(p = 0.159, 
cc = 0.177) (Table 2).
Patients	 were	 grouped	 by	 mean	 MAP	 values	 as	 follows;	 (a)	
low	 (baseline	 MAP	<	99.7	mmHg,	 n = 28) and (b) high (base-
line	 MAP	≥	99.7	mmHg,	 n = 37) in the presymptomatic period, 
TABLE  1 Patient profiles
Number of patients (male/female) 65 (17/48)
Age	(mean,	(median,	range)) 40.0 (36.0, 
11–90)
Medical conditions (n) Chemotherapy- 
immunosup-
pression (26)
Renal failure (22)
Preeclampsia- 
eclampsia (10)
Autoimmune	
disease (9)
Hypertension (4)
Others (6)
F IGURE  2 The distribution of lesion 
scoring point. N, number; LSP, lesion 
scoring point
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and	 (a)	 low	 (onset	 MAP	<	133	mmHg,	 n = 26) and (b) high (onset 
MAP	≥	133	mmHg,	 n = 39) in the symptom onset period respec-
tively.	LSP	was	significantly	higher	in	the	high	MAP	group	than	low	
MAP	group	in	the	presymptomatic	period	(p = 0.004). No statistical 
difference	was	found	in	the	LSP	value	between	low	MAP	and	high	
MAP	groups	at	the	symptom	onset	(p = 0.272).
Patients were classified by underlying medical conditions and the 
mean	pre-	MAP,	onset-	MAP,	and	LSP	were	calculated.	There	were	no	
significant	differences	in	pre-	MAP,	onset-	MAP,	and	LSP	according	to	
medical conditions (Table 3).
4  | DISCUSSION
In this study, we assumed an evolution period before the toxic symp-
tom onset. We collected the BP profiles in the presymptomatic 
and	onset	 periods,	 and	 compared	 lesion	 distribution	with	BPs.	As	
a	result,	LSP	correlated	with	pre-	MAP	although	pre-	MAP	did	with	
onset-	MAP.	Patients	with	 higher	BP	profiles	 appeared	 to	 have	 in-
creased chance of wider lesion distribution than patients with lower 
BP profiles in the presymptomatic period.
There have been several studies concerning the relationship 
between BP at symptom onset, MRI findings, and clinical charac-
teristics. However, their results were incongruent. Bartynski and 
Boardman found four types of cerebral edema pattern which was 
classified by main edema lesion location and symmetricity between 
two	cerebral	hemispheres.	No	significant	association	between	MAP	
at	 toxicity	and	 imaging	patterns,	and	MAP	and	underlying	medical	
conditions was found (Bartynski & Boardman, 2007). Later, they as-
sessed the extent and severity of hemispheric cortex- white matter 
edema by visual grading method. Hemispheric edema was greater 
in normotensive patients than in those with moderate to severe 
hypertension (Bartynski & Boardman, 2008). In a study reported in 
2009, authors also used a visual grading method to measure the ex-
tent of the abnormal signal. In the comparison of the hypertensive 
group and normotensive group at symptom onset, no significant dif-
ferences in the extent of disease and the number of affected brain 
regions between two groups were found. The number of affected 
brain regions was significantly higher in patients with eclampsia, and 
the basal ganglia region was more frequently involved in these pa-
tients (Mueller- Mang et al., 2009). Liman et al. enrolled 96 patients 
with PRES and analyzed the edema severity, lesion distribution, and 
BP profiles on symptom onset period. Lesion distribution was not 
significantly correlated with the type of toxic association. There was 
a	significant	difference	in	MAP	between	toxic	associations.	Onset-	
MAP	was	higher	in	infection,	eclampsia,	and	autoimmune	disorders	
and lower in chemotherapy and immunosuppression related PRES 
cases. There was a trend for higher edema grades to be associated 
with	 higher	 systolic	 BP	 values.	 High	 MAPs	 were	 associated	 with	
incomplete lesion resolution on follow- up MRI (Liman, Bohner, 
Heuschmann, Endres, & Siebert, 2012). This result implies that there 
would be a difference in pathophysiological processes which lead to 
PRES in regard to etiologies and BP may affect the course of PRES.
In a study published in 2012, authors investigated the presymp-
tomatic BP changes in 25 PRES cases and compared with those of 
the controls. They recorded the BP changes over a 48- hr window 
before the PRES symptom onset and calculated the degree of BP 
fluctuation by mathematical formula. The BP fluctuations were not 
more common in PRES cases than in the controls despite of signifi-
cantly increased BP over the 48- hr window. It was suggested that 
PRES cannot be explained solely on the basis of severe acute hyper-
tension or sudden BP surges or fluctuation (Rabinstein et al., 2012). 
Although	 their	 study	 did	 not	 directly	 investigate	 the	 relationship	
between BP at the presymptomatic period and at symptom onset 
Pre- MAP Onset- MAP LSP
Pre-	MAP p < 0.001 (cc = 0.424) p = 0.009 (cc = 0.323)
Onset-	MAP p < 0.001 (cc = 0.424) p = 0.159 (cc = 0.177)
LSP p = 0.009 
(cc = 0.323)
p = 0.159 (cc = 0.177)
Note.	MAP,	mean	arterial	pressure;	LSP,	lesion	scoring	point;	cc,	correlation	coefficient.
TABLE  2 The correlation between 
scoring point and blood pressure
Medical conditions Pre- MAP, mmHg Onset- MAP, mmHg LSP
Total (n = 65) 99.7 ± 13.8 133.0 ± 21.2 7.1 ± 3.1
CTx- IS (n = 29) 96.8 ± 12.8 128.8 ± 22.3 7.0 ± 3.2
Renal failure (n = 22) 102.2 ± 16.3 138.9 ± 21.9 7.5 ± 3.4
Preeclampsia- eclampsia 
(n = 10)
100.2 ± 11.7 127.3 ± 12.4 7.6 ± 2.5
Autoimmune	disease	
(n = 9)
96.6 ± 11.7 129.8 ± 18.2 7.4 ± 2.4
Hypertension (n = 4) 116.8 ± 11.6 140.0 ± 11.5 4.8 ± 2.5
Others (n = 6) 93.2 ± 2.2 129.0 ± 25.2 4.3 ± 2.6
Note. CTx- IS, Chemotherapy- immunosuppression; LSP, lesion scoring point.
TABLE  3 The blood pressure profiles 
and scoring points
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within the PRES cases, their result seems to be contrary to our re-
sult showing the significant BP elevation at the symptom onset com-
pared with the presymptomatic period.
To our knowledge, the relationship between PRES severity and 
pre- BP has not been investigated. It is interesting that LSP as a 
marker of PRES severity was explained better by pre- BP rather than 
onset- BP. In the Doppler study for pre- eclampsia patients who were 
neurologically normal, their autoregulation indices were lower than 
those of healthy controls, suggesting dysfunctional autoregulation 
during presymptomatic period (van Veen et al., 2013). Therefore, we 
presume that higher BP during presymptomatic period may make 
worse the impairment of cerebral autoregulation and may lead to 
more severe PRES. BP elevation during presymptomatic period 
might be a heralding sign of impending PRES or an important factor 
affecting the severity of PRES although BP was not investigated at 
earlier time points. Prompt control of a rising BP would be required 
for the prevention of PRES in patients with risk factors for PRES.
Our study has limitations. First, there may be limitations in the 
detection of clinical symptoms and the estimation of onset time 
because of a retrospective analysis depending on the accuracy of 
medical records. Second, the severity of edematous lesion was not 
evaluated in our study. Only the lesion distribution could not reflect 
lesion severity appropriately. Higher pre- BP may be more likely as-
sociated with the number of affected brain regions rather than with 
disease severity. Third, the required evolution period for the PRES 
generation may differ between individuals. Thus, the information 
about BP at multiple time points before the toxic symptom onset 
is required to investigate the preclinical hemodynamic changes of 
PRES. Fourth, this study included only hospitalized patients, which 
may	produce	selection	bias.	Also,	a	small	number	of	patients	prevent	
to reveal the relationship between etiologies and lesion distribution 
patterns.	Above	all,	BP	is	not	the	sole	controlling	factor	for	cerebral	
autoregulation. Considering the above limitations, a cautious inter-
pretation of the study results is needed.
5  | CONCLUSION
This study may suggest that the patients with PRES who had higher 
BP in the presymptomatic period might be more likely to show wider 
spatial distribution of edematous lesions.
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